Author: Carter, Chris J.
Title: Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease Document date: 2017_9_28
ID: tmpidjrp_87
Snippet: Amelioration of BBB disruption has already been proposed as a potential therapy in AD, and several drugs including angiotensin receptor blockers, etodolac (NSAID), granisetron (5HT3 serotonin receptor antagonist), or beclomethasone (corticosteroid) [249, 250] as well as other NSAIDS, statins, Table 1 The effects of Alzheimer's disease (AD) environmental risk factors and beneficial agents on blood-brain barrier (BBB) function AD risk factor Effect.....
Document: Amelioration of BBB disruption has already been proposed as a potential therapy in AD, and several drugs including angiotensin receptor blockers, etodolac (NSAID), granisetron (5HT3 serotonin receptor antagonist), or beclomethasone (corticosteroid) [249, 250] as well as other NSAIDS, statins, Table 1 The effects of Alzheimer's disease (AD) environmental risk factors and beneficial agents on blood-brain barrier (BBB) function AD risk factor Effects on BBB Aging Aging leads to barrier dysfunction and vascular hyperpermeability in peripheral and BBB [165] Air pollution Long-term air pollution disrupts the BBB in children and young adults and causes neuroinflammation, an altered brain innate immune response, and accumulation of A⤠and alpha-synuclein starting in childhood [ Mild traumatic brain injury produces early disruption of the BBB in animal models and in human [287, 288] . Cerebral hypoperfusion/ischemia (Caused by carotid/leptomeningeal/circle of Willis atherosclerosis or by hypotension)
Search related documents:
Co phrase search for related documents- immune response and neuroinflammation cause: 1, 2
- immune response and potential therapy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
- immune response and receptor antagonist: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
- immune response and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- immune response and serotonin receptor antagonist: 1
- immune response and traumatic brain injury: 1, 2, 3, 4
- immune response and vascular hyperpermeability: 1, 2, 3
- immune response and young adult: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- immune response innate and long term: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- immune response innate and neuroinflammation cause: 1
- immune response innate and potential therapy: 1, 2, 3, 4
- immune response innate and receptor antagonist: 1, 2, 3
- immune response innate and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- immune response innate and traumatic brain injury: 1, 2
- immune response innate and young adult: 1, 2, 3
- long term and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- risk factor and traumatic brain injury: 1, 2, 3, 4, 5, 6, 7, 8
- risk factor and vascular hyperpermeability: 1
- risk factor and young adult: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Co phrase search for related documents, hyperlinks ordered by date